Info@ThinkPinkRocks.com

Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.

Read more here:
Added benefit not proven for orphan drug in treatment of adults with stomach cancer

Share

Leave a Reply